| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,540.50
|
|
Change (%)
|
-40.25 (-2.55%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,505.00
-
1,598.70
|
|
52-Week Range (RS)
|
1,310.05
-
1,672.20
|
|
Beta (1 Year)
|
0.74
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50, BSE GREENEX, bse carbonex |
| News |
|
Corporate Details |
| Cipla consolidated net profit rises 3.73% in the September 2025 quarter |
| Cipla partners with Eli Lilly to distribute Tirzepatide in India under second brand ‘Yurpeak’ |
| Cipla Ltd - Product Launch - Lilly And Cipla Sign Marketing And Distribution Agreement For Second Brand Of Tirzepatide I... |
| Cipla Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Cipla to announce Quarterly Result |
| Volumes soar at TVS Motor Company Ltd counter |
| Cipla Ltd - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday 30Th Oc... |
| Cipla Ltd - Cipla Limited - General Updates : |
| Cipla Ltd - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requir... |
| Cipla Ltd - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
|
|
|
| Incoporation Year : 1935 |
| Chairman : Y K Hamied |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Cipla Ltd Cipla House Peninsula Buss Par, Ganpatrao Kadam Mg Lower Parel, Mumbai, Maharashtra-400013 |
Phone:91-22-24826000 Fax:91-22-24826120 |
| E-Mail : cosecretary@cipla.com, contactus@cipla.com |
| URL : http://www.cipla.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
23-Oct-2025 |
1645.25 |
-3.92 |
| 1Month |
29-Sep-2025 |
1488.55 |
6.19 |
| 3Month |
29-Jul-2025 |
1574.00 |
0.43 |
| 6Month |
29-Apr-2025 |
1541.00 |
2.58 |
| 1Year |
29-Oct-2024 |
1478.10 |
6.94 |
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Flexi Cap Fund |
3.69 |
3156.93 |
| SBI Nifty 50 ETF |
0.75 |
1516.30 |
| Parag Parikh Flexi Cap Fund |
1.25 |
1501.62 |
| SBI ELSS Tax Saver Fund |
3.01 |
916.79 |
| HDFC Focused Fund |
3.83 |
901.98 |
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,703.60 |
-0.75 |
1,923.95 |
1,547.25 |
408,750.71 |
| Mankind Pharma Ltd |
2,445.75 |
0.05 |
3,050.00 |
2,115.50 |
100,950.41 |
| Dr Reddys Laboratories Ltd |
1,202.15 |
-4.03 |
1,404.60 |
1,025.90 |
100,333.09 |
| Zydus Lifesciences Ltd |
986.30 |
-1.55 |
1,059.00 |
797.05 |
99,244.86 |
| Lupin Ltd |
1,945.10 |
-0.60 |
2,403.45 |
1,774.00 |
88,844.81 |
|
|
|
|